APA (7th ed.) Citation

Erdes, S., Mazurov, V. I., Dubinina, T. V., Gaydukova, I. Z., Lapshina, S. A., Zonova, E. V., . . . Ivanov, R. A. Efficacy and safety of a new original interleukin 17A inhibitor in the treatment of patients with active ankylosing spondylitis: Results of a basic (BCD-085-3/AILAS) and extended (BCD-085-3ext/AILAS-II) phase II clinical trial. IMA PRESS LLC.

Chicago Style (17th ed.) Citation

Erdes, Sh, et al. Efficacy and Safety of a New Original Interleukin 17A Inhibitor in the Treatment of Patients with Active Ankylosing Spondylitis: Results of a Basic (BCD-085-3/AILAS) and Extended (BCD-085-3ext/AILAS-II) Phase II Clinical Trial. IMA PRESS LLC.

MLA (9th ed.) Citation

Erdes, Sh, et al. Efficacy and Safety of a New Original Interleukin 17A Inhibitor in the Treatment of Patients with Active Ankylosing Spondylitis: Results of a Basic (BCD-085-3/AILAS) and Extended (BCD-085-3ext/AILAS-II) Phase II Clinical Trial. IMA PRESS LLC.